Abstract: The invention provides methods of analyzing a nucleic acid in a target sample for variant alleles. In such methods, a first-labelled control sample and a second-labelled target sample are hybridized to at least one set of probes. The control sample comprises a homozygous reference allele. The target sample comprises the homozygous reference allele, or variant alleles differing from the reference allele at a locus, or one variant allele differing from the reference allele at the locus and one reference allele. The probes in the probe set span the locus and are complementary to the reference allele. After hybridization the intensity of first and second label bound to each probe in the set is measured. This information is then used to indicate the presence of one variant allele and one reference allele, or the presence of two variant alleles in the target sample.
Type:
Grant
Filed:
November 26, 1997
Date of Patent:
January 11, 2000
Assignee:
The United States of America as represented by the Department of Health and Human Services
Inventors:
Joseph G. Hacia, Mark S. Chee, Francis S. Collins
Abstract: The breakpoints of the pericentric inversion of chromosome 16 have been cloned. Two genes, one at each breakpoint, have also been identified, as well as several forms of the inversion 16 fusion gene. Diagnostic applications for chromosome 16 abnormalities and, particularly acute myeloid leukemia are also within the scope of the present invention.
Type:
Grant
Filed:
September 25, 1995
Date of Patent:
November 17, 1998
Assignees:
The Regents of the University of Michgan, The Board of Regents University of Texas System
Inventors:
Pu Liu, Francis S. Collins, Michael J. Siciliano, David Claxton
Abstract: The cystic fibrosis gene and its gene product are described for both the normal and mutant forms. The genetic and protein information is used in developing DNA diagnosis, protein diagnosis, carrier and patient screening, drug and gene therapy, cloning of the gene and manufacture of the protein, and development of cystic fibrosis affected animals.
Type:
Grant
Filed:
June 6, 1995
Date of Patent:
July 7, 1998
Assignees:
HSC Research Development Corporation, The Board of Regents, Acting for and on Behalf of The University of Michigan
Inventors:
Lap-Chee Tsui, John R. Riordan, Francis S. Collins, Johanna M. Rommens, Michael C. Iannuzzi, Bat-Sheva Kerem, Mitchell L. Drumm, Manuel Buchwald